If you have been researching treatments for male pattern hair loss, you have almost certainly come across finasteride — the most widely prescribed oral medication for this condition. But you may also have heard of dutasteride, a related medication that some clinicians consider a more potent alternative. So how do these two drugs compare, and which one might be right for you?
In this article, we provide a thorough head-to-head comparison of dutasteride and finasteride, covering how they work, how effective they are, their side effect profiles, and the practical considerations that might influence which one your clinician recommends.
Understanding 5-Alpha Reductase Inhibitors
Both dutasteride and finasteride belong to a class of medications called 5-alpha reductase inhibitors (5-ARIs). To understand how they differ, it helps to understand the role of the enzyme they target.
5-alpha reductase is an enzyme that converts testosterone into dihydrotestosterone (DHT). DHT is the hormone primarily responsible for male pattern hair loss — it binds to receptors in genetically susceptible hair follicles, causing them to shrink progressively (a process called follicular miniaturisation) until they produce only fine, barely visible hairs or stop producing hair altogether.
By inhibiting this enzyme, both finasteride and dutasteride reduce DHT levels, slowing or reversing the miniaturisation process and allowing affected follicles to recover. The key difference lies in how they inhibit the enzyme.
The Key Mechanism Difference: Single vs Dual Inhibition
This is the most important distinction between the two medications.
Finasteride: Type II Inhibitor
Finasteride selectively inhibits the type II isoenzyme of 5-alpha reductase. This is the predominant form found in hair follicles, the prostate, and the liver. At a standard dose of 1mg daily (the dose licensed for hair loss), finasteride reduces serum DHT levels by approximately 65-70%.
Dutasteride: Dual Type I and Type II Inhibitor
Dutasteride inhibits both type I and type II isoenzymes of 5-alpha reductase. Type I is found primarily in the skin (including sebaceous glands) and the liver, while type II is the same isoenzyme targeted by finasteride. Because dutasteride blocks both pathways, it achieves a much greater reduction in DHT levels. At a dose of 0.5mg daily, dutasteride reduces serum DHT levels by approximately 90-95% — significantly more than finasteride.
This greater DHT suppression is the theoretical basis for dutasteride being a more potent hair loss treatment. For a deeper dive into how finasteride works at the molecular level, our article on how finasteride works for hair loss provides additional detail.
Effectiveness: What Do the Clinical Trials Show?
Several studies have directly compared dutasteride and finasteride for the treatment of male pattern hair loss. The most significant findings are summarised below.
The ARIA Study (2006)
One of the most important head-to-head trials was a randomised, double-blind study involving 416 men with androgenetic alopecia. Participants were assigned to receive dutasteride (0.1mg, 0.5mg, or 2.5mg daily), finasteride 5mg daily, or placebo for 24 weeks.
Key findings:
- Dutasteride 0.5mg produced a greater increase in hair count than finasteride 5mg (note: 5mg is the dose used for benign prostatic hyperplasia, not the 1mg hair loss dose).
- At 24 weeks, dutasteride 0.5mg increased hair count by an average of 109.6 hairs per defined area, compared to 75.6 hairs for finasteride 5mg.
- Both treatments were significantly better than placebo.
The Shanshanwal Study (2017)
A randomised controlled trial in India compared dutasteride 0.5mg to finasteride 1mg (the standard hair loss dose) over 24 weeks in 90 men. The dutasteride group showed:
- Superior hair density improvement compared to finasteride.
- Greater patient satisfaction scores.
- A comparable side effect profile between the two groups.
Systematic Reviews and Meta-Analyses
A 2019 systematic review and meta-analysis published in the Journal of the American Academy of Dermatology pooled data from multiple studies and concluded that dutasteride 0.5mg was statistically significantly more effective than finasteride 1mg for increasing hair count in men with androgenetic alopecia.
However, it is important to note that while the difference was statistically significant, the clinical difference — what you would actually notice when looking in the mirror — was relatively modest. Both medications produce meaningful improvements, and finasteride remains highly effective for the majority of men.
Summary Comparison Table
| Factor | Finasteride (1mg) | Dutasteride (0.5mg) |
|---|---|---|
| Enzyme inhibition | Type II only | Type I and Type II |
| DHT reduction | ~65-70% | ~90-95% |
| Hair count increase (24 weeks) | Moderate | Slightly greater |
| UK licence for hair loss | Yes (as Propecia/generics) | No (off-label use) |
| Half-life | 6-8 hours | 4-5 weeks |
| Time to clear system | Days | Several months |
| Generic availability | Widely available | Available (as Avodart generics) |
| Typical monthly cost (UK) | Lower | Slightly higher |
Side Effect Profiles Compared
Because both medications work through the same fundamental mechanism — reducing DHT — their side effect profiles are similar. The most commonly reported side effects include:
- Reduced libido (decreased sex drive)
- Erectile difficulty
- Decreased ejaculate volume
- Breast tenderness or enlargement (gynaecomastia) — rare
- Low mood or depression — reported by some users, though a causal link has not been conclusively established
Are Side Effects More Common with Dutasteride?
Because dutasteride suppresses DHT more aggressively than finasteride, there is a theoretical expectation that sexual side effects might be slightly more common. Some clinical data supports this, though the differences are small.
In the ARIA study, sexual side effects were reported by approximately 6-8% of men taking dutasteride, compared to around 4-5% for finasteride. However, these rates were not dramatically different, and both were relatively low.
A key consideration is that side effects with dutasteride may take longer to resolve after discontinuation due to its much longer half-life (discussed below). If a man stops finasteride due to side effects, DHT levels typically recover within days to weeks. With dutasteride, recovery may take several months.
For a comprehensive discussion of finasteride side effects specifically, including what the clinical evidence shows about their frequency and reversibility, our finasteride side effects guide provides detailed information.
Half-Life: A Critical Difference
One of the most significant practical differences between these two medications is their half-life — the time it takes for the drug concentration in your blood to reduce by half.
Finasteride: 6-8 Hours
Finasteride has a relatively short half-life of six to eight hours. This means the drug is cleared from your system within a few days of stopping. While DHT suppression lasts somewhat longer than the drug’s presence in the blood, levels return to baseline relatively quickly after discontinuation.
Practical implication: If you experience side effects and stop finasteride, they should resolve relatively quickly. This short half-life also means that daily dosing is important for consistent DHT suppression.
Dutasteride: 4-5 Weeks
Dutasteride has an extraordinarily long half-life of approximately four to five weeks. This means that after stopping the medication, it takes several months for the drug to be fully cleared from your system — some studies suggest it can take six months or longer for DHT levels to return to baseline.
Practical implication: The long half-life means that side effects, if they occur, may persist for a considerable period after discontinuation. On the positive side, it also means that an occasional missed dose has very little impact on DHT suppression, making dutasteride more forgiving of imperfect compliance.
This extended half-life is a significant factor in treatment decisions. Men who are trying a 5-ARI for the first time are often started on finasteride precisely because its shorter half-life means any side effects will resolve more quickly if the medication needs to be stopped.
UK Licensing and Prescribing Status
This is an important regulatory distinction that affects how these medications are accessed in the UK.
Finasteride
Finasteride 1mg (branded as Propecia, with generic versions widely available) is licensed by the MHRA specifically for the treatment of male pattern hair loss. This means it has undergone formal regulatory review for this indication, with established safety and efficacy data supporting its use for this purpose. It is available on prescription from any UK prescriber.
For a complete overview of finasteride, including its history, dosing, and prescribing information, see our complete guide to finasteride.
Dutasteride
Dutasteride 0.5mg (branded as Avodart, with generic versions available) is licensed in the UK only for benign prostatic hyperplasia (BPH) — an enlarged prostate condition. It is not licensed for hair loss in the UK or in most other countries. Using it for hair loss constitutes off-label prescribing.
Off-label prescribing is legal and common in the UK — clinicians can prescribe any licensed medication for an unlicensed indication if they believe it is in the patient’s best interest and they take responsibility for the prescribing decision. However, it does mean that dutasteride has not been formally evaluated by the MHRA specifically for the treatment of hair loss.
South Korea and Japan are notable exceptions — dutasteride is licensed for androgenetic alopecia in both countries. For more detail on dutasteride as a treatment, our comprehensive dutasteride guide covers everything you need to know.
Cost Comparison
In the UK, both finasteride and dutasteride are available as generics, which has made both relatively affordable. However, there are some differences:
- Generic finasteride 1mg is very widely prescribed and produced by multiple manufacturers, keeping prices competitive. It is generally the cheaper option.
- Generic dutasteride 0.5mg is also available at a reasonable cost, though it tends to be slightly more expensive than finasteride. The price difference is usually modest.
Because dutasteride is prescribed off-label for hair loss, it cannot be obtained through the NHS for this indication. Both medications would typically need to be obtained through a private prescription or an online clinic like Evernu.
When Might Dutasteride Be Preferred?
Given that finasteride is licensed, well-studied, and effective for the majority of men, why would a clinician consider dutasteride? There are several scenarios where it may be appropriate.
Finasteride Non-Responders
Some men take finasteride consistently for twelve months or more and do not see adequate improvement. For these individuals, dutasteride’s greater DHT suppression may provide additional benefit. Some men who did not respond to finasteride have reported positive results after switching to dutasteride.
Aggressive or Early-Onset Hair Loss
Men with particularly aggressive hair loss patterns, or those who begin losing hair at a very young age, may benefit from the more potent DHT suppression offered by dutasteride. The rationale is that more aggressive hair loss may require more aggressive treatment.
After Adequate Trial of Finasteride
Most clinicians — and NICE clinical guidelines — recommend trying finasteride first, as it has a more favourable licensing status, a shorter half-life (making side effects more quickly reversible), and is effective for the majority of men. Dutasteride is typically considered a second-line option for those who have not responded adequately to finasteride after a sufficient trial period (usually at least twelve months).
When Might Finasteride Be Preferred?
Finasteride remains the first-line oral treatment for male pattern hair loss for several good reasons:
- Licensed indication: It is specifically approved for hair loss in the UK, providing a higher level of regulatory confidence.
- Shorter half-life: If side effects occur, they resolve more quickly after discontinuation.
- Extensive long-term data: Finasteride has been used for hair loss since the late 1990s, providing decades of real-world safety and efficacy data.
- Lower cost: Generic finasteride is generally cheaper than generic dutasteride.
- Proven effectiveness: The evidence base for finasteride in hair loss is robust, with multiple large-scale trials and long-term follow-up studies. Our article on the evidence for finasteride reviews this data in detail.
Can You Switch from Finasteride to Dutasteride?
Yes. Switching from finasteride to dutasteride is straightforward and can be done without a washout period. Your clinician will typically advise you to simply stop finasteride and start dutasteride the following day. The long half-life of dutasteride means that it will build up in your system gradually over the first few weeks.
If you are considering switching, it is worth noting that you should allow at least six to twelve months on dutasteride before assessing whether it is providing better results than finasteride did. Hair growth cycles are slow, and meaningful comparisons require time.
What About Combining Both?
Taking finasteride and dutasteride together is not recommended. They work through the same mechanism, and dutasteride already provides more potent inhibition than finasteride. Combining them would not provide additional benefit and would only increase the risk of side effects.
A more productive combination approach is to pair either finasteride or dutasteride with minoxidil, which works through a completely different mechanism. Our guide to using minoxidil explains how to incorporate it alongside a 5-ARI for maximum benefit.
What About Women?
Neither finasteride nor dutasteride is licensed for use in women in the UK. Both medications can cause birth defects and must not be taken by women who are pregnant or may become pregnant. Women should not even handle crushed or broken tablets of either medication. Any use in women of childbearing age requires specialist supervision and reliable contraception.
Key Takeaways
- Both dutasteride and finasteride are 5-alpha reductase inhibitors that reduce DHT levels to treat male pattern hair loss.
- Dutasteride inhibits both type I and type II 5-alpha reductase, while finasteride inhibits only type II.
- Dutasteride reduces DHT by approximately 90-95%, compared to 65-70% for finasteride.
- Clinical trials show dutasteride is statistically slightly more effective than finasteride, though the practical difference is modest.
- Side effect profiles are similar, though dutasteride may have a marginally higher rate of sexual side effects.
- Dutasteride has a much longer half-life (4-5 weeks vs 6-8 hours), meaning side effects take longer to resolve after stopping.
- Finasteride is licensed for hair loss in the UK; dutasteride is off-label for this indication.
- Most clinicians recommend starting with finasteride and considering dutasteride only if the response is inadequate after twelve months.
- Both can be effectively combined with minoxidil for enhanced results.
If you are considering treatment for hair loss, visit our hair loss treatment page to explore your options, or speak to one of our clinicians about which treatment might be most appropriate for your situation.
This article is for informational purposes only and does not constitute medical advice. Always speak to a qualified healthcare professional before starting any new treatment. Content reviewed by the Evernu clinical team.
